Speakers

<span id=Dan Barouch">

Dan Barouch

Centre for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, USA

Dr. Dan Barouch received his Ph.D. in immunology from Oxford University and his M.D. from Harvard Medical School. He is currently the William Bosworth Castle Professor of Medicine and Professor of Immunology at Harvard Medical School, Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, a member of the Ragon Institute of MGH, MIT, and Harvard, and part of the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery.

Dan Barouch">

View full bio

<span id=Sarah Gilbert">

Sarah Gilbert

University of Oxford, UK

Talk Title: Preclinical and clinical development of ChAdOx1 nCoV-19

Dr. Gilbert completed her undergraduate studies at the University of East Anglia and her doctoral degree at the University of Hull.  Following four years as a research scientist at the biopharmaceutical company Delta Biotechnology she joined the Nuffield Department of Medicine (NDM) at Oxford University in 1994 and became part of the Jenner Institute (within NDM) when it was founded in 2005.

Sarah Gilbert">

View full bio

<span id=Barney Graham">

Barney Graham

NIAID Vaccine Research Center, USA

Talk Ttile: Rapid COVID-19 countermeasure development demonstrates how generalizable solutions for vaccine antigen design support a prototype pathogen approach for pandemic preparedness

Dr. Graham is Deputy Director and Chief of the Viral Pathogenesis Laboratory at the NIAID Vaccine Research Center. He has a BA from Rice University, an MD from the University of Kansas School of Medicine, and a PhD in Microbiology & Immunology from Vanderbilt University School of Medicine.

Barney Graham">

View full bio

<span id=Paul Klenerman">

Paul Klenerman

University of Oxford, UK

Talk Title: COVID-19 T cell responses

Paul Klenerman trained in infectious diseases at Cambridge, Oxford and London, and holds the Truelove chair in gastroenterology at Oxford. He has been funded by the Wellcome through the fellowship programme for a DPhil in Oxford on HIV and postdoctoral work in Zurich with Rolf Zinkernagel on LCMV, and established a lab in Oxford to study T cell responses to viral infections such as hepatitis C, including work on vaccines.

Paul Klenerman">

View full bio

<span id=Heidi Larson">

Heidi Larson

London School of Hygiene & Tropical Medicine, UK

Talk Title: COVID-19:  Vaccine reluctance and refusal on the rise

Heidi J. Larson, PhD, is Professor of Anthropology, Risk and Decision Science and Director of the Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine. She is also Clinical Professor and Director of European Initiatives at the Institute of Health Metrics and Evaluation, University of Washington, Seattle, USA, and Associate Professor, Centre for Evaluation of Vaccination, University of Antwerp, Belgium.

Heidi Larson">

View full bio

<span id=Giovanni Rezza">

Giovanni Rezza

Director of the Department of Infectious Diseases at the Istituto Superiore di Sanità, Roma, Italy

Talk Title: Vaccine Acceptance

More information coming soon...

Giovanni Rezza">

View full bio